Tian JY - Search Results

1

Effects of cyclooxygenase-2 gene silencing on the biological behavior of SKOV3 ovarian cancer cells.

Guo FJ, Tian JY, Jin YM, Wang L, Yang RQ, Cui MH. Guo FJ, et al. Among authors: tian jy. Mol Med Rep. 2015 Jan;11(1):59-66. doi: 10.3892/mmr.2014.2732. Epub 2014 Oct 21. Mol Med Rep. 2015. Retraction in: Mol Med Rep. 2021 Oct;24(4):707. doi: 10.3892/mmr.2021.12346 PMID: 25335121 Free PMC article. Retracted.

2

Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.

Guo F, Tian J, Lin Y, Jin Y, Wang L, Cui M. Guo F, et al. J Int Med Res. 2013 Oct;41(5):1456-61. doi: 10.1177/0300060513487652. Epub 2013 Aug 20. J Int Med Res. 2013. PMID: 23963852 Free article.

3

The role of F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) in the screening of cervical cancer: a literature review.

Guo F, Yang R, Tian J, Fan L. Guo F, et al. Cell Biochem Biophys. 2014 Jun;69(2):197-201. doi: 10.1007/s12013-013-9788-0. Cell Biochem Biophys. 2014. PMID: 24272282 Review.

4

[Application of two and three-dimensional ultrasound measurement of fetal thymus in fetal intrauterine growth restriction].

Yang R, Guo F, Liu X, Tian J, Fan L. Yang R, et al. Zhonghua Yi Xue Za Zhi. 2014 Sep 9;94(33):2607-9. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25511494 Chinese.

5

Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo.

Guo F, Tian J, Cui M, Fang M, Yang L. Guo F, et al. Mol Med Rep. 2015 Jul;12(1):753-9. doi: 10.3892/mmr.2015.3425. Epub 2015 Mar 4. Mol Med Rep. 2015. Retraction in: Mol Med Rep. 2021 Nov;24(5):751. doi: 10.3892/mmr.2021.12391 PMID: 25738807 Retracted.

6

Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities.

Tian JY, Guo FJ, Zheng GY, Ahmad A. Tian JY, et al. Carcinogenesis. 2018 Mar 8;39(3):307-317. doi: 10.1093/carcin/bgx141. Carcinogenesis. 2018. PMID: 29216344 Review.

7

Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.

Guo F, Zhang H, Jia Z, Cui M, Tian J. Guo F, et al. Am J Cancer Res. 2018 Jul 1;8(7):1317-1331. eCollection 2018. Am J Cancer Res. 2018. PMID: 30094104 Free PMC article. Review.

8

Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation.

Tian J, Guo F, Chen Y, Li Y, Yu B, Li Y. Tian J, et al. Cancer Lett. 2019 Apr 28;448:1-10. doi: 10.1016/j.canlet.2019.01.002. Epub 2019 Jan 20. Cancer Lett. 2019. PMID: 30673592

9

A novel GPCR target in correlation with androgen deprivation therapy for prostate cancer drug discovery.

Tian JY, Chi CL, Bian G, Guo FJ, Wang XQ, Yu B. Tian JY, et al. Basic Clin Pharmacol Toxicol. 2021 Feb;128(2):195-203. doi: 10.1111/bcpt.13499. Epub 2020 Dec 1. Basic Clin Pharmacol Toxicol. 2021. PMID: 32991779 Free article. Review.

10

PSMA conjugated combinatorial liposomal formulation encapsulating genistein and plumbagin to induce apoptosis in prostate cancer cells.

Tian JY, Chi CL, Bian G, Xing D, Guo FJ, Wang XQ. Tian JY, et al. Colloids Surf B Biointerfaces. 2021 Jul;203:111723. doi: 10.1016/j.colsurfb.2021.111723. Epub 2021 Mar 26. Colloids Surf B Biointerfaces. 2021. PMID: 33839474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters